Clinical non-penetrance associated with biallelic mutations in the RNase H2 complex
暂无分享,去创建一个
Y. Crow | M. Zamani | G. Rice | I. Maystadt | M. Wagner | G. Coarelli | L. González-Granado | C. David | Lucie Pierron | Luis I Giulia Lucie Isabelle Matias Mina Saeid Clémence Gonzalez-Granado Coarelli Pierron Maystadt W | Saeid Sadeghian | Giulia Coarelli
[1] A. Vanderver,et al. Genetic and phenotypic spectrum associated with IFIH1 gain-of-function , 2020, Human mutation.
[2] Y. Crow,et al. Treatments in Aicardi–Goutières syndrome , 2020, Developmental medicine and child neurology.
[3] A. Herrick,et al. RNASEH2B Related Adult-Onset Interferonopathy , 2019, Journal of Clinical Immunology.
[4] A. Moser,et al. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots. , 2017, Molecular genetics and metabolism.
[5] L. Lagae,et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 , 2015, American journal of medical genetics. Part A.